Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Abstract Natural killer (NK) cells are implicated among immune effectors after vaccination against viral pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen, adenovirus type 26.ZEBOV followed by modified vaccinia Ankara-BN-Filo (EBOVAC2 consortium, EU Innovative M...

Full description

Saved in:
Bibliographic Details
Main Authors: Helen R. Wagstaffe, Giada Susannini, Rodolphe Thiébaut, Laura Richert, Yves Lévy, Viki Bockstal, Jeroen N. Stoop, Kerstin Luhn, Macaya Douoguih, Eleanor M. Riley, Christine Lacabaratz, Martin R. Goodier
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/9fcd68f95a2b493f8092a3429bbfd28d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/9fcd68f95a2b493f8092a3429bbfd28d

Similar Items